- Home
- SNGX vs AMST Comparison
SNGX vs AMST Comparison
Compare SNGX & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- AMST
- Stock Information
- Founded
- SNGX 1987
- AMST 2017
- Country
- SNGX United States
- AMST United States
- Employees
- SNGX N/A
- AMST N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- AMST Computer Software: Prepackaged Software
- Sector
- SNGX Health Care
- AMST Technology
- Exchange
- SNGX Nasdaq
- AMST Nasdaq
- Market Cap
- SNGX 10.1M
- AMST 13.3M
- IPO Year
- SNGX 1987
- AMST 2020
- Fundamental
- Price
- SNGX $2.75
- AMST $3.47
- Analyst Decision
- SNGX Strong Buy
- AMST
- Analyst Count
- SNGX 1
- AMST 0
- Target Price
- SNGX $6.00
- AMST N/A
- AVG Volume (30 Days)
- SNGX 10.0M
- AMST 2.1M
- Earning Date
- SNGX 11-07-2025
- AMST 11-13-2025
- Dividend Yield
- SNGX N/A
- AMST N/A
- EPS Growth
- SNGX N/A
- AMST N/A
- EPS
- SNGX N/A
- AMST N/A
- Revenue
- SNGX N/A
- AMST $82,544.00
- Revenue This Year
- SNGX N/A
- AMST N/A
- Revenue Next Year
- SNGX N/A
- AMST N/A
- P/E Ratio
- SNGX N/A
- AMST N/A
- Revenue Growth
- SNGX N/A
- AMST N/A
- 52 Week Low
- SNGX $1.09
- AMST $2.00
- 52 Week High
- SNGX $6.23
- AMST $6.27
- Technical
- Relative Strength Index (RSI)
- SNGX 48.17
- AMST 62.90
- Support Level
- SNGX $2.58
- AMST $2.62
- Resistance Level
- SNGX $2.98
- AMST $4.78
- Average True Range (ATR)
- SNGX 0.21
- AMST 0.27
- MACD
- SNGX -0.09
- AMST 0.11
- Stochastic Oscillator
- SNGX 21.79
- AMST 39.91
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.